Ameriprise’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-17,428
| Closed | -$75K | – | 3739 |
|
|
2017
Q4 | $75K | Sell |
17,428
-24,500
| -58% | -$105K | ﹤0.01% | 3570 |
|
|
2017
Q3 | $59K | Sell |
41,928
-35,528
| -46% | -$50K | ﹤0.01% | 3619 |
|
|
2017
Q2 | $117K | Sell |
77,456
-55,814
| -42% | -$84.3K | ﹤0.01% | 3633 |
|
|
2017
Q1 | $343K | Buy |
133,270
+28,110
| +27% | +$72.3K | ﹤0.01% | 3285 |
|
|
2016
Q4 | $268K | Buy |
105,160
+25,750
| +32% | +$65.6K | ﹤0.01% | 3529 |
|
|
2016
Q3 | $245K | Buy |
79,410
+775
| +1% | +$2.39K | ﹤0.01% | 3482 |
|
|
2016
Q2 | $252K | Buy |
78,635
+13,245
| +20% | +$42.4K | ﹤0.01% | 3440 |
|
|
2016
Q1 | $202K | Buy |
65,390
+3,370
| +5% | +$10.4K | ﹤0.01% | 3520 |
|
|
2015
Q4 | $249K | Sell |
62,020
-440
| -0.7% | -$1.77K | ﹤0.01% | 3549 |
|
|
2015
Q3 | $286K | Buy |
62,460
+13,040
| +26% | +$59.7K | ﹤0.01% | 3467 |
|
|
2015
Q2 | $256K | Buy |
49,420
+13,490
| +38% | +$69.9K | ﹤0.01% | 3672 |
|
|
2015
Q1 | $225K | Buy |
+35,930
| New | +$225K | ﹤0.01% | 3539 |
|
|
2014
Q4 | – | Sell |
-135
| Closed | -$1K | – | 4793 |
|
|
2014
Q3 | $1K | Sell |
135
-4,485
| -97% | -$33.2K | ﹤0.01% | 5596 |
|
|
2014
Q2 | $30K | Sell |
4,620
-8,400
| -65% | -$54.5K | ﹤0.01% | 4134 |
|
|
2014
Q1 | $310K | Buy |
13,020
+10
| +0.1% | +$238 | ﹤0.01% | 3091 |
|
|
2013
Q4 | $139K | Sell |
13,010
-1,899
| -13% | -$20.3K | ﹤0.01% | 3284 |
|
|
2013
Q3 | $198K | Hold |
14,909
| – | – | ﹤0.01% | 3182 |
|
|
2013
Q2 | $196K | Buy |
+14,909
| New | +$196K | ﹤0.01% | 3097 |
|